Bottom line: MeAgain is built for where GLP-1 tracking is going toward tracking, context, and support in one GLP-1-first place
Damiano, M., Galvan, L., Deglon, N
This allows once-weekly dosing schedules in sustained research protocols and reduces result variability introduced by more frequent administration windows a key advantage for multi-week structured studies
Transcriptome profiling of in vitro -matured oocytes from a Korean native cow (hanwoo) after cysteamine supplementation
Reports have shown that, between 2022 and 2023, almost 25,000 people went to the emergency room for side effects caused by the GLP-1 drugs, like Ozempic, that they take to manage their diabetes or off-label for weight loss
For people exploring GLP-1 options, our MeAgain GLP-1 app provides personalized support throughout the decision-making process